Literature DB >> 15516236

Influence of retrograde flushing via the caval vein on the post-reperfusion syndrome in liver transplantation.

Kniepeiss Daniela1, Zink Michael, Iberer Florian, Schaffellner Silvia, Jakoby Estrella, Duller Doris, Tscheliessnigg Karl-Heinz.   

Abstract

INTRODUCTION: The reperfusion phase during orthotopic liver transplantation (LTX) is a critical event with sometimes profound hemodynamic and cardiac changes. We present the influence of retrograde reperfusion in LTX on the post-reperfusion syndrome (PRS).
METHODS: Fifty-six LTXs in 53 patients were performed with the piggy-back technique with retrograde reperfusion via the caval vein and antegrade reperfusion via the portal vein. The incidence of PRS was evaluated.
RESULTS: We observed a PRS in two patients (3.6%), four patients (7.1%) had a decrease in mean arterial pressure (MAP) of 20-29%, 18 patients (32.2%) of 10-19%, 27 patients (48.2%) of 1-9% and five patients (8.9%) had a small increase in MAP. DISCUSSION: Our retrospective study showed that retrograde reperfusion seems to maintain stability during the reperfusion phase. Hemodynamic disturbances during LTX were uncommon, leading us to suppose that the incidence of PRS could be diminished with retrograde reperfusion.

Entities:  

Mesh:

Year:  2004        PMID: 15516236     DOI: 10.1111/j.1399-0012.2004.00231.x

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  13 in total

1.  Serum acidosis prior to reperfusion facilitates hemodynamic recovery following liver transplantation.

Authors:  Kyota Fukazawa; Alexander A Vitin; Ernesto A Pretto
Journal:  J Anesth       Date:  2015-10-08       Impact factor: 2.078

2.  Elevated effluent potassium concentrations predict the development of postreperfusion hyperkalemia in deceased liver transplantation: a retrospective cohort study.

Authors:  Liang Zhang; Fu-Shan Xue; Ming Tian; Zhi-Jun Zhu
Journal:  BMC Anesthesiol       Date:  2022-05-25       Impact factor: 2.376

3.  Use of transesophageal Doppler as a sole cardiac output monitor for reperfusion hemodynamic changes during living donor liver transplantation: An observational study.

Authors:  M Hussien; E Refaat; N Fayed; K Yassen; M Khalil; W Mourad
Journal:  Saudi J Anaesth       Date:  2011-07

4.  Refractory Hypotension after Liver Allograft Reperfusion: A Case of Dynamic Left Ventricular Outflow Tract Obstruction.

Authors:  Michael Essandoh; Andrew Joseph Otey; Adam Dalia; Elisabeth Dewhirst; Andrew Springer; Mitchell Henry
Journal:  Front Med (Lausanne)       Date:  2016-02-16

5.  Association Between Flushed Fluid Potassium Concentration and Severe Postreperfusion Syndrome in Deceased Donor Liver Transplantation.

Authors:  Liang Zhang; Ming Tian; Liying Sun; Zhijun Zhu
Journal:  Med Sci Monit       Date:  2017-10-29

6.  Prognostic Value of Model for End-Stage Liver Disease Incorporating with Serum Sodium Score for Development of Acute Kidney Injury after Liver Transplantation.

Authors:  Yuan Cheng; Guo-Qing Wei; Qiu-Cheng Cai; Yi Jiang; Ai-Ping Wu
Journal:  Chin Med J (Engl)       Date:  2018-06-05       Impact factor: 2.628

7.  Post-reperfusion syndrome during renal transplantation: a retrospective study.

Authors:  Steven R Bruhl; Sandeep Vetteth; Michael Rees; Blair P Grubb; Samer J Khouri
Journal:  Int J Med Sci       Date:  2012-07-16       Impact factor: 3.738

Review 8.  Postreperfusion syndrome during liver transplantation.

Authors:  Sung-Moon Jeong
Journal:  Korean J Anesthesiol       Date:  2015-11-25

Review 9.  Expanded Criteria Donor-Related Hyperkalemia and Postreperfusion Cardiac Arrest During Liver Transplantation: A Case Report and Literature Review.

Authors:  Liang Zhang; Ming Tian; Lin Wei; Zhijun Zhu
Journal:  Ann Transplant       Date:  2018-07-03       Impact factor: 1.530

10.  Diagnosis, Incidence, Predictors and Management of Postreperfusion Syndrome in Pediatric Deceased Donor Liver Transplantation: A Single-Center Study.

Authors:  Liang Zhang; Ming Tian; Fushan Xue; Zhijun Zhu
Journal:  Ann Transplant       Date:  2018-05-18       Impact factor: 1.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.